Project Grant R01EY036440
Award Date
9/1/24
Completion Date
4/30/29
Dollars Obligated
$2.2M
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $588,731 to The University of Iowa to investigate the role of ferroptosis, a type of oxidative cell death, in the progression of Fuchs Endothelial Corneal Dystrophy (FECD). The key research objectives are to: 1) Define the interplay between FECD-associated corneal guttae and ferroptosis, 2) Determine how ultraviolet-A light exposure mediates ferroptosis in FECD, and 3) Develop drug therapies to...
The National Eye Institute (NEI) awarded a $451,962 Project Grant (CFDA 93.867 Vision Research) to The Regents of the University of California, San Francisco (UCSF) to develop novel mouse models for studying the role of Transcription Factor 4 (TCF4) trinucleotide repeat expansions in the pathogenesis of Fuchs Endothelial Corneal Dystrophy (FECD). The research aims to generate and characterize TCF4 repeat expansion mouse models, as well as to investigate how the TCF4 repeat expansion...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the human eye. The $543,037 award, effective September 1, 2024 through May 31, 2028, will fund investigations into the genetic and molecular mechanisms underlying corneal development and function. Key research objectives include identifying transcription factors and...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 - Vision Research) in the amount of $753,189 to Trustees of Boston University, doing business as Boston University Medical Campus, with a period of performance from August 1, 2024 to May 31, 2029. The grant will support research to identify novel therapeutic targets for corneal epithelial defects by revealing the differential roles of basal epithelial cells in the central cornea, limbus, and conjunctiva in corneal health and...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), supports research to investigate the relationship between myofibroblasts and alloreactive T cells in corneal transplantation. The $540,213 award to The Schepens Eye Research Institute, Inc., effective August 1, 2025 through July 31, 2030, aims to: 1) define the mechanisms by which myofibroblasts regulate alloreactive effector T cell function, and 2) define the mechanisms by...
The National Eye Institute (NEI) awarded a $176,550 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Louisville to optimize C-Met signaling to enhance corneal epithelial homeostasis. The research aims to extend C-Met receptor activity by disrupting its downregulation, with the goal of restoring corneal homeostasis following wounding. The study will investigate the role of C-Met ubiquitylation in limiting its signaling in corneal epithelial cells in...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $246,000 to The Regents of the University of California, San Francisco to conduct research on serum components that support corneal health. The goal is to define the combinations of serum factors, such as growth factors, signaling lipids, and vitamins, that can restore healthy corneal function and treat diverse ocular surface disorders. The research aims to improve the clinical use of...
The National Eye Institute (NEI) awarded a $431,750 Project Grant under the Vision Research program (CFDA 93.867) to the University of California, Irvine (UCI) to develop a novel femtosecond laser-based approach for non-viral corneal gene delivery. The key objectives are to create microchannels through the corneal epithelium to enhance transepithelial diffusion, and use subthreshold laser pulses to open membrane pores in stromal keratocytes for safer plasmid-based gene delivery without the...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides funding to investigate whether estrogen is protective or detrimental to the health of corneal endothelial cells. The total award amount is $1,414,183.00 over the project period from Sep 30, 2024 to Apr 30, 2028. The key objectives are to: 1) Measure corneal thickness, endothelial cell density and morphology in male and female estrogen receptor knockout mice over one year, and examine endothelial...
The federal Project Grant award of $433,125.00, awarded by the National Eye Institute (CFDA 93.867 Vision Research program), supports research aimed at inhibiting corneal neovascularization (CNV) by targeting tissue factor (TF). The Ohio State University will conduct studies to define dosages and time windows for systemically administering a TF-targeting agent (L-ICON3) as a monotherapy, as well as determine potential synergistic effects of L-ICON3 combined with other tissue repair factors, to...